Summer School 2023

Summer School in Translational Cancer Research, October 8 – 14, 2023, Portugal

The CCE Summer School in Translational Cancer Research is intended to provide an in-depth training of scientists and clinicians to gain a cross-disciplinary knowledge of areas of the entire cancer research continuum.

The Summer School covers a broad spectrum of topics ranging from basic and clinical research to the implementation of scientific insights into the health care system. An important goal of the Summer School is the interaction between participants as well as speakers, coming from both preclinical laboratories and clinical centers worldwide. We aim at stimulating interactions to foster multidisciplinary collaborations at an international level. Participants have the opportunity to present their research projects and data in oral or poster presentations.

Registration for the 2023 Summer School will open mid-April

Program

↑ Top of the page

The detailed programme of the Summer School will be published here soon.

Main topics for the Summer School

Location

↑ Top of the page

Doctoral and postdoctoral researchers, clinician scientists as well as international speakers from many different countries meet at the beautiful hotel Porto Bay Falesia in Portugal.

VENUE

Hotel PortoBay Falésia
Quinta do Milharó, Olhos de Água
8200-591 Albufeira – Portugal

embed maps

WHAT OUR PARTICIPANTS SAY

↑ Top of the page

Prince Anand, India: “The heterogeneity of the crowd is really where you get to know more and more people from different parts of the world, and what they are doing in the clinical setting, as well as in the labs. Different activities – just like a walk on a beach or soccer on a beach helps you to get to know more and more people and it helps you to mingle with the people of your own research interest.“

Tania Christiansen, Germany: “What I enjoyed most so far is really that you interact with many different people from different disciplines and also different career levels. You can actually get a lot of inspiration on your own projects.“

Gunn Amitzbøll, Denmark: “I would like to say thank you for an absolute fantastic week in Portugal! I have never experienced a more successful event, both socially and professionally!”

Rihan El Bezawy, Italy: “Especially in this very challenging war against cancer, we really need to stand together, because the whole is greater than the sum of its parts, so we need to be a core against cancer. And this is definitely what I found here in Cancer Core Europe.“

Omnia Elebyary, Egypt: “I like the diversity here, and the creativity, and how everyone gets to interact based on his own background.“

Andreas Mock, Germany: “Summer School brings people together, it creates opportunity, it gives us an important stimulus, and really fosters collaboration between young researchers.“

SCIENTIFIC COMMITTEE

↑ Top of the page

Dr. Nick Tobin
Karolinska Institutet (KI)
Stockholm, Sweden

Dr. Irene Braña
Vall d’Hebron Institute of Oncology (VHIO)
Barcelona, Spain

Dr. Richard Baird
Cancer Research UK Cambridge Centre
Cambridge, United Kingdom

Prof. Svetlana Bajalica Lagercrantz
Karolinska Institutet (KI)
Stockholm, Sweden

Prof. Ingemar Ernberg
Karolinska Institutet (KI)
Stockholm, Sweden

Dr. Marleen Kok
The Netherlands Cancer Institute (NKI)
Amsterdam, The Netherlands

Prof. Stefan Fröhling,
National Center for Tumor Diseases (NCT) – DKFZ
Heidelberg, Germany

Dr. Priya Chudasama,
National Center for Tumor Diseases (NCT) – DKFZ
Heidelberg, Germany

Dr. Delia Mezzanzanica,
Istituto Nazionale dei Tumori di Milano (INT)
Milan, Italy

Dr. Thomas Mercher,
Institut Gustave Roussy (IGR)
Villejuif, France

Dr. Mate Maus
Vall d’Hebron Institute of Oncology (VHIO)
Barcelona, Spain

ORGANISERS

↑ Top of the page

	An alliance of 7 leading European cancer centers

SUPPORTERS

The German Cancer Consortium (DKTK) is a long-term, joint initiative involving the German Federal Ministry of Education and Research (BMBF), participating German states and the German Cancer Research Center (DKFZ) and was established as one of six German Health Research Centres (DZGs) in 2012. The German Cancer Research Center, the consortium’s core center, works together with more than 20 academic research institutions and university hospitals in Berlin, Dresden, Essen/Düsseldorf, Frankfurt/Mainz, Freiburg, Munich and Tübingen to create the best possible conditions for preclinical-translational cancer research. The consortium promotes interdisciplinary research at the interface between basic research and clinical research. Another key focus of the consortium’s work is on developing research platforms to speed up the application of personalized cancer treatments and to improve the diagnosis and prevention of cancer.

The mission of Cancer Prevention Europe (CPE), a consortium of organizations across the whole of Europe, is to reduce morbidity and mortality from cancer in European populations through prevention and earlier detection of the disease. This will be accomplished through (1) research to optimize the implementation of known preventive strategies, (2) the dissemination of established best practices in prevention, in order to see innovative research translated into effective cancer prevention guidelines and policies nationally and internationally, and (3) research to identify novel targets for prevention.